Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Philadelphia, Pennsylvania
- Most recent report
- 8-K, filed Aug 5, 2026
- Incorporated
- Delaware
- Filings on record
- 307 filings
- On EDGAR
- CIK 1842952
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 8 of 20
News 8 of 53
Prospectuses and Registrations 8 of 42
- S-8 Registration statement for an employee plan Mar 23, 2026
- 424B5 Prospectus supplement for an offering Oct 24, 2025
- S-8 Registration statement for an employee plan Mar 20, 2025
- 424B5 Prospectus supplement for an offering Dec 2, 2024
- S-3 Shelf registration statement Nov 6, 2024
- 424B3 Prospectus supplement for an offering May 31, 2024
- S-3 Shelf registration statement May 24, 2024
- S-8 Registration statement for an employee plan Mar 21, 2024
Proxies 8 of 16
- DEFA14A Extra proxy material Apr 28, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2026
- PRE 14A Preliminary proxy statement Apr 17, 2026
- DEFA14A Extra proxy material Apr 15, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 15, 2025
- PRE 14A Preliminary proxy statement Apr 4, 2025
- DEFA14A Extra proxy material Jul 24, 2024
- DEF 14A Proxy statement for a shareholder vote Jul 24, 2024
Ownership 8 of 133
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 12, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Jul 31, 2026
- SCHEDULE 13G Large holder reported a passive stake Jul 27, 2026
- 4 Insider reported a trade Jun 26, 2026
- 4 Insider reported a trade Jun 26, 2026
- 4 Insider reported a trade Jun 26, 2026
- 4 Insider reported a trade Jun 26, 2026
Other 8 of 43
- ARS Annual report sent to shareholders Apr 28, 2026
- ARS Annual report sent to shareholders Apr 15, 2025
- EFFECT Notice that a registration became effective Nov 14, 2024
- CORRESP Reply to SEC staff Nov 12, 2024
- UPLOAD Comment letter from SEC staff Nov 12, 2024
- EFFECT Notice that a registration became effective May 31, 2024
- CORRESP Reply to SEC staff May 29, 2024
- UPLOAD Comment letter from SEC staff May 29, 2024
Everything here comes from Context Therapeutics Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.